TrialAnnals of the rheumatic diseases2013

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study.

Dae Hyun Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.